Genomelink
PrivateLast Round
Series A
Dec 1, 2021
Total Funding Raised
$23.01M
Company Overview
Genomelink is a biotechnology company that operates a personal genomics platform allowing users to upload raw DNA data to access insights on ancestry, wellness, and personality traits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomelink Comparables
Compare Genomelink with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| yourDNAportal | 87% | |
| NutraHacker | 84% | |
| Sequencing.com | 83% |
Genomelink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2021 | ||||
| Seed | Jul 1, 2021 | ||||
| Seed | Nov 30, 2018 | ||||
| Seed | Jan 1, 2018 | ||||
| Seed | Aug 22, 2017 |
Key People
Founding team and executive leadership
Genomelink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coral Capital | Series A |
| Sony Ventures Corporation | Series A |
| 500 Global | Seed |
| Global Brain Corporation | Seed |
| DG Daiwa Ventures | Seed |
| Ironfire Ventures | Seed, Series A |
| Asymmetry Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2021
$10M raised from Asymmetry Ventures, Liquid 2 Ventures, and others.
Genomelink Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomelink's valuation, stock price, and market status.
Is Genomelink a public or private company?
Genomelink is a private company.
What is the current stock price of Genomelink?
Genomelink is a private company with no public stock price. No recent secondary market data is available.
How much is Genomelink worth (valuation)?
Valuation information for Genomelink is not publicly available.
Can I buy Genomelink stock?
Genomelink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomelink's last funding round?
Genomelink's most recent funding round was Series A on December 1, 2021.
Who are the main investors in Genomelink?
Key investors in Genomelink include Coral Capital, Sony Ventures Corporation, 500 Global, Ironfire Ventures, Berkeley SkyDeck.
Will Genomelink IPO soon?
No public IPO plans have been announced for Genomelink.
How can I track Genomelink secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomelink's secondary market activity and sign up for updates.